The loss of epithelial cell polarity plays an important role in the development and progression of liver cancer. However, the specific molecular mechanisms supporting tumor initiation and progression are poorly understood. In this study, transcriptome data and immunofluorescence stains of tissue samples derived from hepatocellular carcinoma (HCC) patients revealed that overexpression associated with cytoplasmic localization of the basolateral cell polarity complex protein scribble (Scrib) correlated with poor prognosis of HCC patients. In comparison with HCC cells stably expressing wild-type Scrib (Scrib WT ), mutated Scrib with enforced cytoplasmic enrichment (Scrib P305L ) induced AKT signaling through the destabilization of phosphatase and tensin homolog (PTEN) and PH domain and leucine-rich repeat protein phosphatase 1 (PHLPP1). Cytoplasmic Scrib P305L stimulated a gene signature and a phenotype characteristic for epithelial to mesenchymal transition (EMT) and HCC cell invasiveness. Scrib P305L -dependent invasion was mediated by the activator protein 1 (AP-1) constituents ATF2 and JunB through induction of paracrine-acting secreted protein acidic and cysteine-rich (SPARC). Coexpression of Scrib P305L and the oncogene c-MYC through hydrodynamic gene delivery in mouse livers promoted tumor formation and increased abundance of pAKT, pATF2, and SPARC in comparison with controls. Finally, cytoplasmic Scrib localization correlated with AKT and ATF2 phosphorylation in human HCC tissues, and the Scrib P305L -dependent gene signature was enriched in cancer patients with poor prognosis. Conclusion: Perturbation of hepatocellular polarity due to overexpression and cytoplasmic enrichment of Scrib supports tumor initiation and HCC cell dissemination through specific molecular mechanisms. Biomarker signatures identified in this study can be used for the identification of HCC patients with higher risk for the development of metastasis.
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The loss of epithelial cell polarity plays an important role in the development and progression of liver cancer. However, the specific molecular mechanisms supporting tumor initiation and progression are poorly understood. In this study, transcriptome data and immunofluorescence stains of tissue samples derived from hepatocellular carcinoma (HCC) patients revealed that overexpression associated with cytoplasmic localization of the basolateral cell polarity complex protein scribble (Scrib) correlated with poor prognosis of HCC patients. In comparison with HCC cells stably expressing wild-type Scrib (Scrib WT ), mutated Scrib with enforced cytoplasmic enrichment (Scrib P305L ) induced AKT signaling through the destabilization of phosphatase and tensin homolog (PTEN) and PH domain and leucine-rich repeat protein phosphatase 1 (PHLPP1). Cytoplasmic Scrib P305L stimulated a gene signature and a phenotype characteristic for epithelial to mesenchymal transition (EMT) and HCC cell invasiveness. Scrib P305L -dependent invasion was mediated by the activator protein 1
(AP-1) constituents ATF2 and JunB through induction of paracrine-acting secreted protein acidic and cysteine-rich (SPARC). Coexpression of Scrib P305L and the oncogene c-MYC through hydrodynamic gene delivery in mouse livers promoted tumor formation and increased abundance of pAKT, pATF2, and SPARC in comparison with controls. Finally, cytoplasmic Scrib localization correlated with AKT and ATF2 phosphorylation in human HCC tissues, and the Scrib P305L -dependent gene signature was enriched in cancer patients with poor prognosis. Conclusion: Perturbation of hepatocellular polarity due to overexpression and cytoplasmic enrichment of Scrib supports tumor initiation and HCC cell dissemination through specific molecular mechanisms. Biomarker signatures identified in this study can be used for the identification of HCC patients with higher risk for the development of metastasis. (HEPATOLOGY 2018; 67:1842 -1856 ).
E pithelial cells must maintain a high degree of polar organization to sustain their biological functions. This structural organization includes the formation of layered, columnar, and cuboidal sheets or three-dimensional structures such as tubules and trabeculae. Three multiprotein polarity complexes establish and preserve the apical-basal polarity of epithelial cells. (1) The Crumbs complex consists of Crumbs3 (Crb3), protein associated with lin seven-1 (PALS1), as well as PALS1-associated tight junction protein (PATJ) and defines apical cell areas, while the partitioning defective 3 (PAR3), PAR6, and atypical protein kinase C (aPKC) complex physically associates with tight junction structures. The basolateral cell area depends on the presence of the Scrib complex, which consists of Scribble (Scrib), discs
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large (DLG), and lethal giant larvae homolog (LGL). Importantly, dynamic composition of the individual complexes as well as mutual regulation between complex constituents is central for the maintenance and dynamic adjustment of cell polarity in epithelial cells under physiological conditions. (1) The three-dimensional trabecular structure of hepatocytes, in particular, is crucial for the spatial liver organization, which allows directed blood flow from the portal triad to the central vein through sinusoids as well as the secretion and transport of bile through bile canaliculi and bile ducts. For this, hepatocytes acquire a unique multipolar architecture depending on the presence of cell polarity complexes. (2) The formation of distinct apical and basolateral domains as well as the spatial organization of hepatocytes is necessary for cell-cell contact and for vectorial trafficking of macromolecules such as plasma proteins, bile acid, toxic compounds, nutrients, and growth factors into and from the blood stream as well as the biliary tract. In addition, membrane compartmentalization mediates the activation of signaling pathways in distinct cell areas, which integrates extracellular information to control biological functions such as cell proliferation and differentiation. (3) The loss of polarization and spatial organization in epithelial cells impairs their ability to control cell growth and migration as observed in tumor formation and cell dissemination. (4) Indeed, for many cancer types, accumulating evidence shows that changes in cell polarity protein abundance, mutations, and mislocalization directly support tumor formation and progression. For example, the loss of lateral complex proteins, which are necessary for adherens junctions functionality (e.g., LGL1 and LGL2) induces dysplasias of neuronal progenitors. (5) The clinical relevance of retained cell polarity is illustrated by heterozygous mutations of the liver kinase B1 (LKB1; synonyms: PAR4/STK11), which causes benign hamartomatous polyps of the gastrointestinal tract, partly through the negative regulation of the Hedgehog pathway. (6) The loss of cellular polarity is a key feature in carcinogenesis and one important pathological parameter for the identification of early events in many epithelial tumors. (7) For the liver, disturbed hepatocellular polarity is defined by excessive matrix deposition during liver fibrosis and cirrhosis, which reduces the cell contact with sinusoidal blood or neighboring hepatocytes, eventually leading to regenerative nodules surrounded by extracellular matrix. (2) The development of several liver disorders is associated with the dysregulation of cell polarity factors, and the direct impact of proteins such as LKB1 and inositol polyphosphate phosphatase-like 1 (INPPL1) on hepatocarcinogenesis has been discussed. (8) However, whether the aberrant expression of cell polarity factors involved in the formation and maintenance of apical, basal, and basolateral polarity complexes contribute to hepatocarcinogenesis and how these factors support liver tumor development and progression is poorly understood.
In this study, we screened for dysregulated proteins important for a three-dimensional hepatocellular structure whose overexpression correlates with poor patient outcome. We identified the basolateral complex protein Scribble (Scrib), whose altered expression and mislocalization were associated with poor clinical outcome. On the one hand, cytoplasmic Scrib stimulated HCC cell invasiveness through induction of activator protein 1 (AP-1) (ATF2/JunB)-dependent secreted protein acidic and cysteine-rich (SPARC) secretion. On the other hand, mislocalized Scrib supported tumor formation in conjunction with the oncogene c-MYC in vivo. Cytoplasmic Scrib and activation of AKT, ATF2, and SPARC correlated in human HCC tissue cohorts and Scrib-induced gene signatures defined patient groups with poor clinical outcome.
Materials and Methods
Antibodies, primers, and small interfering RNA (siRNA) sequences are listed in Supporting Tables S1 and S2. A detailed description of all in vivo and in vitro analyses, sample preparation, expression profiling, tissue-microarray analyses, bioinformatics, and statistical procedures is provided in the Supporting Information.
PATIENT MATERIAL
Transcriptome data of primary human HCCs and corresponding nontumorous liver tissues of 249 HCC patients were used in this study. (9) Expression levels of 33 polarity genes were compared between HCCs (n 5 249) and nontumorous livers (n 5 239). Chromosomal gains and losses were calculated by reanalyzing comparative genomic hybridization array data derived from 60 HCC patients. (10) Five-micrometer cryosections of noncirrhotic, nontumorous human liver tissues and human HCCs were stained with hematoxylin & eosin. All samples were evaluated histologically by two pathologists, and carcinomas were graded using the Edmondson system. If tumor necrosis/hemorrhage was >50% of the section size, the sample was excluded. 
MOUSE WORK
The experimental setup and group size was approved by the German Regional Council of BadenWuerttemberg (Karlsruhe, Germany; reference number G-30/16) and in accordance with the institutional regulations of the Interfakult€ are Biomedizinische Forschungseinrichtung (University of Heidelberg, Germany). Exclusion and termination criteria are defined by criteria of the animal welfare officer of the University Hospital Heidelberg.
Results

OVEREXPRESSION AND CYTOPLASMIC ENRICHMENT OF Scrib IN HCC CELLS
Disturbance of spatial cellular organization due to dysregulation of cell polarity proteins represents an important step in hepatocarcinogenesis. Therefore, we analyzed the expression of 33 cell polarity complex proteins (Crumbs/PALS/PATJ, PAR3/PAR6/aPKC, and Scrib/DLG/LGL complexes) or factors involved in the formation of junction structures (e.g., a-catenin/ CTNNA) using transcriptome data derived from HCC patients (Supporting Table S3 ). (2, 9) According to the selection criteria (significantly upregulated in HCC and association with poor/good prognosis), four candidate genes were identified: Scrib, CDC42, a-catenin/CTNNA1, and DLG5, with Scrib showing the highest average overexpression and most significant correlation with poor overall survival and cancer recurrence ( Fig. 1A,B ; Supporting Fig. S1A -C). To test if increased Scrib overexpression was due to chromosomal gains, the genomic status of the Scrib gene locus on chromosome 8q24.3 was compared with Scrib messenger RNA (mRNA) levels using highresolution, comparative genomic hybridization array data (n 5 60). (10) The results illustrate that in HCCs with chromosomal gains, Scrib mRNA amounts were significantly higher compared with cases without genomic alterations (Fig. 1C) .
Next, the subcellular Scrib localization in primary human livers and HCC tissues was tested using immunofluorescence. Although Scrib was localized at the plasma membrane in hepatocytes of healthy livers in 90% of all cases (18/20), a cytoplasmic enrichment was detectable in 69% of HCC cases (22/32; Fig. 1D ). A comparison of Scrib mRNA levels and the subcellular protein localization illustrated that Scrib overexpression is associated with its cytoplasmic enrichment, suggesting that higher Scrib levels may contribute under certain conditions to its cytoplasmic enrichment (Fig.  1E ). To identify in vitro models for further analyses, we compared Scrib protein levels in immortalized hepatocytes (THLE-2) and HCC cell lines. Scrib protein amounts were higher in most HCC cells in comparison with THLE-2 cells (Supporting Fig. S2A ). Importantly, immunofluorescence stains revealed for some cell lines a clear membranous Scrib localization (HepG2, HuH1, HuH6), while other cells exhibited a cytoplasmic Scrib enrichment (e.g., HuH7) ( 
CYTOPLASMIC Scrib SUPPORTS HCC CELL INVASION
Scrib mutations, which may cause cytoplasmic enrichment, are rare events in human hepatocarcinogenesis (about 1%-2%; http://www.cbioportal.org/). However, to analyze the impact of cytoplasmic and membranous Scrib on HCC cell biology, we stably overexpressed wildtype Scrib (Scrib WT ) or a Scrib isoform carrying an "artificial" mutation in the leucinerich repeats domain, resulting in its cytoplasmic enrichment (Scrib   P305L   ) . (11, 12) This mutation has not been described in human carcinogenesis; however, it allows us to direct the subcellular localization of Scrib in genetically modified cells. For transfection, we chose HepG2 cells because endogenous Scrib was localized in close proximity to the membrane (Fig. 1F ). HepG2 cells with stable Scrib WT overexpression showed a clear membranous Scrib enrichment, whereas cells with stable Scrib P305L overexpression displayed a predominant cytoplasmic positivity ( Fig. 2A,B) .
Because Scrib palmitoylation by the palmitoyl acyltransferase zinc finger DHHC-type containing 7 (ZDHHC7) is regulating its subcellular localization, (13) we tested whether this modification differs between HepG2 cells stably expressing both Scrib isoforms. Indeed, Scrib P305L palmitoylation, which is associated with its membranous localization, was significantly reduced compared with Scrib WT (Fig. 2C ). This suggested that in addition to overexpression, secondary protein modifications are involved in Scrib mislocalization in hepatocarcinogenesis.
Overexpression of Scrib WT led to the formation of more compact and piled colonies, whereas expression of Scrib P305L was associated with loose cell clusters, the latter indicative of a less pronounced cell polarity (Fig. 2D) . To test whether cytoplasmic Scrib P305L expression affects hepatocellular polarity, both cell lines were propagated in sandwich cultures. Immunofluorescence analysis of the apical multidrug resistanceassociated protein 2 (MRP2) confirmed the formation of distinct canalicular structures in colonies of Scrib WT cells, whereas Scrib P305L cells showed drastically shorter or no canalicular networks (Fig. 2E) .
Functional assays revealed that Scrib P305L cells exhibited moderate effects on cell viability and cytotoxicity compared with cells expressing membranous Scrib WT (Supporting Fig. S2C,D) . The most obvious biological effect of cytoplasmic Scrib P305L was observed for cell invasion. Whereas Scrib WT overexpressing cells did not show a strong invasive capacity, the transmigration ability was significantly higher in Scrib P305L overexpressing cells (Fig. 2F ). This was supported by the observation that Scrib P305L cells developed long protruded actin filaments, which was indicative for a migratory phenotype, and elevated Rho/GTPases in comparison with Scrib WT cells (Supporting Fig. S2F ).
CYTOPLASMIC Scrib INDUCES AKT PHOSPHORYLATION
Previous work has demonstrated that Scrib is involved in the regulation of the Hippo/yes-associated protein (YAP) pathway, which affects hepatocellular proliferation and HCC cell migration. (14, 15) However, YAP localization and phosphorylation were not regulated by Scrib in different experimental setups, suggesting that Scrib affects HCC cell invasion in a YAPindependent manner (Supporting Fig. S3A,B) .
Because Scrib may affect ERK1/2 and PI3K/AKT pathway activity, (16, 17) we tested whether key pathway constituents were differentially phosphorylated by membranous and cytoplasmic Scrib. Although no obvious differences between ERK1/2 or JNK1/2 phosphorylation in Scrib WT and Scrib P305L expressing cells were observed, cells with cytoplasmic Scrib exhibited increased activation/phosphorylation of AKT and its downstream target S6 (Fig. 2G ). This was confirmed by a more pronounced AKT phosphorylation in Scrib P305L -expressing cells after wortmannin-and BKM120-mediated inhibition of PI3K, illustrating higher AKT activity in the absence of its physiological upstream regulator (Supporting Fig. S3C,D) . As described for other cell systems, two upstream negative regulators of AKT, phosphatase and tensin homolog (PTEN), and PH domain and leucine-rich repeat protein phosphatase 1 (PHLPP1) were destabilized in Scrib P305L cells due to elevated ubiquitination (Supporting Fig. S4) . (17, 18) Because both phosphatases dephosphorylate AKT, reduced PTEN and PHLPP1 abundance in Scrib P305L expressing cells might be one explanation for the observed induction of AKT phosphorylation.
IDENTIFICATION OF TUMOR-SUPPORTING DOWNSTREAM MECHANISMS OF CYTOPLASMIC Scrib
Our results indicated effects of cytoplasmic Scrib on HCC cell invasiveness. To determine the molecular mechanism connecting cytoplasmic Scrib and tumor cell dissemination, we performed transcriptome analysis of cells expressing Scrib WT and Scrib P305L . Expression data revealed down-regulation of many WNT pathway inhibitors in Scrib P305L -expressing cells (e.g., BICC1, DKK1, DKK4) ( Fig. 3A and Supporting Table S4 ). In addition, 19 of 81 induced genes in cells with cytoplasmic Scrib have been described in the context of cell migration/invasion, epithelial to mesenchymal transition (EMT), extracellular matrix remodeling, and cytoskeletal reorganization. Increased expression of these genes was confirmed by quantitative polymerase chain reaction (PCR) (N-cadherin, CEACAM1, Fascin1, SPARC, TIMP1, TIMP2, S100A10, and MCAM; Fig. 3B ), Western immunoblotting (N-cadherin, CEACAM1, and Fascin1; Fig.  3C ), and by enzyme-linked immunosorbent assay (ELISA) (secreted protein acidic and cysteine rich; SPARC), (Fig. 3D) . In addition, a cytoplasmic mislocalization of E-cadherin and an induction of membranous N-cadherin expression were observed by immunofluorescence (Fig. 3E) . Together, these results illustrate that cells with cytoplasmic Scrib localization show characteristics of an EMT phenotype.
With a 133-fold induction at the mRNA and 7-fold increase at the protein levels, SPARC (osteonectin) represented the most prominent downstream effector for cytoplasmic Scrib. Because SPARC has been described as potent regulator of cell migration, (19) we hypothesized that Scrib P305L facilitates its promigratory properties through the induction of SPARC. Indeed, SPARC administration on Scrib WToverexpressing cells significantly increased their invasive capacity (Fig. 3F) . By contrast, the siRNAmediated knockdown of SPARC expression in Scrib P305L cells abolished their invasive phenotype (Fig. 3G) .
Scrib REGULATES SPARC THROUGH ACTIVATION OF ACTIVATOR PROTEIN 1
It has been demonstrated that PI3K/AKT signaling induces the transcription factors SP1 as well as activator protein 1 (AP-1). Because SPARC can be regulated by both factors, (20, 21) we hypothesized that cytoplasmic Scrib stimulates SPARC secretion through induction of SP1 and/or AP-1.
Although SP1 binds the SPARC promoter in HCC cells, no differences between SP1 expression in Scrib WT and Scrib P305L cells and no effect on SPARC secretion after SP1 inhibition were detectable (Supporting Fig. S5 ). In contrast, we observed a strong induction of ATF2 and JunB phosphorylation in Scrib P305L cells, whereas the total amounts of both proteins (but not mRNA) increased moderately (Fig.  4A,B) . The Scrib P305L -dependent gene signature indicative for EMT and tumor cell was reduced after ATF2 (Fig. 4C) or JunB inhibition (Fig. 4D) , suggesting that the observed invasive phenotype in Scrib P305L cells was partly due to the induction of AP-1 activity. Notably, JunB showed stronger effects than ATF2 on EMT gene expression and invasionassociated genes (Fig. 4C,D) . Silencing of ATF2 and JunB significantly reduced SPARC transcript level and protein secretion in Scrib P305L cells (Fig. 4C-E) , whereas no such changes were observed in Scrib WT cells (Fig. 4E) . With regard to SPARC, ATF2 was a stronger regulator than JunB.
Lastly, we tested whether ATF2 and JunB physically interact with binding sites within the SPARC promoter. According to the JASPAR database, two potential AP-1 binding sites were predicted in the promoter ( Fig. 4F ; site 1, positions 2469 to 2360; site 2, positions 11890 to 11998). (22) Chromatin immunoprecipitation analysis revealed no significant differences of ATF2 and JunB binding between the potential binding sites and a downstream control region in Scrib WT cells. In contrast, significantly higher affinity of both AP-1 constituents was detected in Scrib comparison with the respective control primers (Fig.  4F ), indicating that both transcription factors promote SPARC expression in cells with cytoplasmic Scrib.
CYTOPLASMIC Scrib PROMOTES c-MYC-INDUCED TUMOR FORMATION
Activation of Scrib-induced AKT signaling may synergize with oncogenes in hepatocytes. Interestingly, the c-myc gene is equally located on chromosome 8q24.21 in close proximity to the Scrib gene on chromosome 8q24.3 and is therefore frequently amplified in human HCC. (23) We therefore investigated whether the codelivery of c-MYC and Scrib WT/P305L isoforms (with Scrib P305L leading to AKT activation) through hydrodynamic gene delivery affects c-MYC-dependent tumor formation in polarized hepatocytes. This technique was chosen because it allows the genetic manipulation of few hepatocytes (in comparison with all parenchymal cell in transgenic mice) and a moderate and steady expression of EF1a promoter transgenes in comparison with cytomegalovirus (CMV) promoter.
Isolation of livers 4 weeks after vector injection followed by the evaluation of a pathologist showed the first small tumor nodules in a mice expressing green fluorescent protein (GFP)/c-MYC (Fig. 5A) . In GFP-Scrib WT /c-MYC livers, only one microscopically visible tumor was detectable. In contrast, the highest number of macro-and microscopically visible tumors were detectable in mice expressing GFP-Scrib P305L / c-MYC. Although 10%-15% of all hepatocytes are usually transiently positive for the injected transgenes (data not shown), (24) increased levels of Scrib P305L -induced signature genes and an activation of AKT were as observed in samples with c-MYC/Scrib P305L coexpression in comparison with c-MYC/Scrib WT samples (Fig. 5B,C) . Immunohistochemical analysis revealed a prominent induction of AKT and ATF2 phosphorylation as well as SPARC and Fascin1 production in tumors induced by c-MYC/Scrib P305L , but not in control tumors (Fig. 5D) . Moreover, the expression of polarity markers such as apical MRP2 and basolateral integrin b1 was lost in c-MYC/Scrib P305L -induced tumors (Fig. 5E ).
Scrib-DEPENDENT GENE SIGNATURE EXPRESSION CORRELATES WITH POOR PATIENT PROGNOSIS
Finally, we aimed to confirm our findings in a cohort of human normal livers and HCC samples. Immunohistochemical stains of Scrib, pAKT, E-cadherin, and pATF2 showed a significant correlation between high-level cytoplasmic Scrib and activation/phosphorylation of AKT (r s 5 0.54, P 0.001) (Fig. 6A) . Moreover, cytoplasmic Scrib was negatively associated with membranous E-cadherin expression (r s 5 20.49, P 0.001) and elevated activation/ phosphorylation of ATF2 (r s 5 0.28, P 5 0.037).
Cytoplasmic Scrib and the loss of membranous E-cadherin correlated with tumor dedifferentiation (cyto Scrib: r s 5 0.24, P 5 0.02; E-cadherin: r s 5 20.21, P 5 0.04). For pAKT, a nonsignificant tendency between its phosphorylation and dedifferentiation was also detectable (P 5 0.1) (Fig. 6B) . In addition, Scrib P305L -induced signature genes including SPARC, MCAM, CDH2, and S100A10 were significantly increased in HCC tissues compared with normal liver tissues (Fig. 6C) . Their overexpression was associated with poor overall survival and early tumor recurrence, which further supported the relevance of these factors in hepatocarcinogenesis (Supporting Fig. S6 ). (Fig. 3) , 65/81 genes that were up-regulated in Scrib P305L cells and 16/19 genes associated with EMT and invasiveness were used. The normalized enrichment score (NES) reflects the degree of overrepresentation for each group at the peak of the entire set. The nominal P value was calculated based on the enrichment score by using an empirical phenotype-based permutation test. (E) Gene set enrichment analysis of genes reduced in Scrib P305L cells (46/54 genes were listed) in prognostic subgroups of HCC.
We then tested whether the presence of genes regulated by Scrib P305L was enriched in patients with poor overall survival (genes listed in Fig. 3A) . (25) Indeed, gene set enrichment analysis demonstrated a significant association of Scrib P305L -induced genes (n 5 65) and genes involved in cell invasiveness (n 5 16) with poor patient prognosis (Fig. 6D) . By contrast, negatively regulated genes were enriched in the patient group with better clinical outcome (n 5 46) (Fig. 6E) . This finding demonstrates that cytoplasmic Scrib is associated with elevated AKT/AP-1 activity and that the presence of Scrib P305L -dependent gene signatures defines patients with increased invasiveness and poor clinical outcome of HCC patients.
Discussion
The tumor-suppressive function of epithelial cell polarity is well accepted, and its disturbance has been observed frequently during the early stages of tumor development. (1) In this context, a number of factors such as LKB1, PAR3/PAR6, aPKCf/i/k, and DLG1/ 2/3 that are involved in the formation and maintenance of cell polarity are dysregulated in solid tumors due to altered expression, mislocalization, or mutation.
(1) However, the underlying molecular mechanisms connecting polarity with liver cancer cell proliferation and motility are not well understood. Here, we show that the basolateral polarity protein Scrib is overexpressed and mislocalized in human liver cancer cells and that its dysregulation in hepatocytes supports tumor initiation and HCC cell dissemination in early and late phases of hepatocarcinogenesis.
Establishment and maintenance of hepatocyte polarity is of critical importance for hepatocellular biology, including the production and secretion of bile into bile canaliculi as well as their permanent exchange of substances with the blood stream.
(2) Disturbance of hepatocyte polarization may occur during hepatic diseases, including hepatitis C infections, cholestasis, and hyperbilirubinemia due to impairment of the trabecular architecture. (8) By contrast, genetic alterations of polarity genes have been implicated in the pathogenesis of liver diseases. For example, mutations and allelic losses of LKB1 have been detected in HCC, and the heterozygous deletion of LKB1 in mice is sufficient to induce HCC formation. (26) Moreover, mutations in b-catenin or AXIN family members led to the oncogenic nuclear enrichment of the transcriptional coactivator b-catenin. (27) With Scrib, we add another polarity factor to this list of genes, which affect liver tumor development and progression. The Scrib/DLG/LGL complex is a key regulator for spatial orientation of epithelial structures, and the functional loss of all three proteins is associated with tumor-supporting properties. (28) Indeed, Scrib is dysregulated in different tumor diseases, including breast cancer, in which it induces cell proliferation and cell invasiveness. (29) Both elevated and reduced expression of Scrib have been described in tumorigenesis; however, our own and previously published results illustrate that cytoplasmic Scrib localization alone is sufficient to promote tumor formation. (18, 29) Different mechanisms may contribute to the observed Scrib mislocalization, such as simple overexpression (high Scrib levels correlated with its cytoplasmic enrichment; Fig. 1E ) but also alterations of secondary modifications such as palmitoylation (Fig.  2C) . (13) Our data also support the idea that disturbance of the three-dimensional cellular organization can directly support tumor initiation-here in conjunction with the oncogene c-MYC, which is frequently amplified in human HCCs-and that the cessation of hepatocellular polarity is not merely a consequence of malignant transformation. These findings of our study are supported by a very recent publication showing that Scrib is overexpressed and mislocalized in human HCC. (16) Notably, our results showed strong positive effects of cytoplasmic Scrib on AKT signaling, but not on ERK1/2 or JNK signaling. Different effects were published for breast cancer and liver cells, where Scrib overexpression affected ERK1/2 activation and EMT. (16, 30) It is unclear whether these differences (regulation of AKT or ERK1/2) are due to cell type specific properties or if the differential localization of Scrib allows the regulation of both pathways under specific experimental conditions. However, a prominent induction of the AP-1 constituents ATF2 and JunB is detectable in HCC cells with cytoplasmic Scrib expression. Because AKT induces AP-1 activity, (31) and because ERK1/2 phosphorylation was not affected by Scrib localization in our cell systems, an AKTdependent activation of ATF2 and JunB probably mediates the expression of EMT markers in cells with cytoplasmic Scrib.
The 32-35 kDa secreted factor SPARC is strongly induced by cytoplasmic Scrib as well as ATF2/JunB activation. Our results demonstrate that SPARC is a central mediator of Scrib P305L -mediated invasiveness, suggesting that SPARC facilitates tumor dissemination in later stages of tumorigenesis. SPARC is a regulator of matrix organization, and it has been shown that SPARC can induce the migration of several different cancer cell types such as glioma cells. (32) However, SPARC activity seems to depend on context and cell type, because tumorsuppressive properties have also been described. (19) We show that SPARC overexpression is connected to the abolishment of cell polarity in liver cancer. This process is not due to unspecific effects or mere consequences of cellular dedifferentiation, but rather represents a specific molecular mechanism involving the activation of AKT and AP-1.
SPARC is a strong inducer of HCC invasiveness because it stimulates HepG2 transmigration. This is supported by data showing that SPARC is part of a signature characterizing HCC cells with high invasive capacity. (33) Interestingly, SPARC interacts with the transmembrane receptor protein stabilin-1, which is highly expressed on the surface of liver sinusoidal endothelial cells. (34) This would indicate that the cytoplasmic localization of Scrib followed by SPARC secretion not only facilitates tumor-autonomous mechanisms but also affects the biology of other liverresident and nonparenchymal cell types.
Importantly, the findings of this study may also influence the development of personalized therapeutic approaches for cancer patients. Although reestablishment of cellular polarity in cancer cells or premalignant lesions is to our knowledge not possible, specific downstream effector mechanisms may represent promising therapeutic target structures for a subgroup of cancer patients with distinct alterations of cell polarity factors. In case of Scrib overexpression and its cytoplasmic enrichment, the specific inhibition of AKT/mTOR pathway activity by US Food and Drug Administration (FDA)-approved chemical compounds or perturbation of SPARC/stabilin-mediated signaling may offer direct points of intervention. (35) Moreover, our results also suggest that gene signatures induced by cytoplasmic Scrib or SPARC overexpression might be used for the identification of cancer patients with higher risk for tumor metastasis and early cancer recurrence as well as for patient stratification.
